PVX-001: open-source Covid-19 vaccine starts Phase 1 trial
发生了什么
First participants safely dosed in Melbourne, Australia, on August 31, 2026, in the first-in-human trial of our broadly-protective COVID-19 vaccine candidate PVX-001.
摘要按规则整理自下方来源原文
First participants safely dosed in Melbourne, Australia, on August 31, 2026, in the first-in-human trial of our broadly-protective COVID-19 vaccine candidate PVX-001.
摘要按规则整理自下方来源原文